SECTOR
Healthcare
COUNTRY
China
Scroll Up Top
Print icon
Print
Invested on
Dec 2009
Transaction Type
Minority Investment
Realization Date
May 2018
Exit Type
Public Market Relisting
Sihuan Pharmaceutical is engaged in the research, manufacturing, marketing and sales of pharmaceutical drugs in China.
 

As of October 10, 2024. The above is provided for informational and educational purposes only. There is no guarantee that the investment mentioned resulted in positive performance (for realized holdings), or will perform well in the future (for current holdings). The trademarks and service marks above are the property of their respective owners. The information on this website has not been authorized, sponsored, or otherwise approved by such owners. By clicking on any links shown here, you agree that you are navigating to a third party site. We are providing these hyperlinks to you only as a convenience and the inclusion of any hyperlink is not and does not imply any endorsement, approval, investigation, verification or monitoring by us of any information contained in any hyperlinked site. In no event shall we be responsible for the information contained on the site or your use of such site.

 
Capital Seeker